These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 20117946)
21. A new player in the orchestra of cell growth: SREBP activity is regulated by mTORC1 and contributes to the regulation of cell and organ size. Porstmann T; Santos CR; Lewis C; Griffiths B; Schulze A Biochem Soc Trans; 2009 Feb; 37(Pt 1):278-83. PubMed ID: 19143646 [TBL] [Abstract][Full Text] [Related]
22. PI3K-Akt signaling pathway upregulates hepatitis C virus RNA translation through the activation of SREBPs. Shi Q; Hoffman B; Liu Q Virology; 2016 Mar; 490():99-108. PubMed ID: 26855332 [TBL] [Abstract][Full Text] [Related]
23. SREBP: a novel therapeutic target. Xiao X; Song BL Acta Biochim Biophys Sin (Shanghai); 2013 Jan; 45(1):2-10. PubMed ID: 23257291 [TBL] [Abstract][Full Text] [Related]
27. [PI3K-AKT network roles in infectious diseases]. Noguchi M; Kinowaki K Kansenshogaku Zasshi; 2008 May; 82(3):161-7. PubMed ID: 18546844 [TBL] [Abstract][Full Text] [Related]
28. Phosphatidylinositol transfer proteins: negotiating the regulatory interface between lipid metabolism and lipid signaling in diverse cellular processes. Ghosh R; Bankaitis VA Biofactors; 2011; 37(4):290-308. PubMed ID: 21915936 [TBL] [Abstract][Full Text] [Related]
29. Singularity analysis of the AKT signaling pathway reveals connections between cancer and metabolic diseases. Wang G Phys Biol; 2010 Dec; 7(4):046015. PubMed ID: 21178243 [TBL] [Abstract][Full Text] [Related]
30. Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth. Griffiths B; Lewis CA; Bensaad K; Ros S; Zhang Q; Ferber EC; Konisti S; Peck B; Miess H; East P; Wakelam M; Harris AL; Schulze A Cancer Metab; 2013 Jan; 1(1):3. PubMed ID: 24280005 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-mediated regulation of lipid metabolism in virus-infected Emiliania huxleyi. Zhang E; Gao J; Wei Z; Zeng J; Li J; Li G; Liu J ISME J; 2022 Nov; 16(11):2457-2466. PubMed ID: 35869388 [TBL] [Abstract][Full Text] [Related]
32. Targeting lipid metabolism with natural products: A novel strategy for gastrointestinal cancer therapy. Guo C; Zhang L; Zhao M; Ai Y; Liao W; Wan L; Liu Q; Li S; Zeng J; Ma X; Tang J Phytother Res; 2023 May; 37(5):2036-2050. PubMed ID: 36748953 [TBL] [Abstract][Full Text] [Related]
33. Recent Insights Into SREBP as a Direct Mediator of Kidney Fibrosis via Lipid-Independent Pathways. Dorotea D; Koya D; Ha H Front Pharmacol; 2020; 11():265. PubMed ID: 32256356 [TBL] [Abstract][Full Text] [Related]
34. Research progress of SREBP and its role in the pathogenesis of autoimmune rheumatic diseases. Xu X; Jin W; Chang R; Ding X Front Immunol; 2024; 15():1398921. PubMed ID: 39224584 [TBL] [Abstract][Full Text] [Related]
35. SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target. Yuan S; Chu H; Chan JF; Ye ZW; Wen L; Yan B; Lai PM; Tee KM; Huang J; Chen D; Li C; Zhao X; Yang D; Chiu MC; Yip C; Poon VK; Chan CC; Sze KH; Zhou J; Chan IH; Kok KH; To KK; Kao RY; Lau JY; Jin DY; Perlman S; Yuen KY Nat Commun; 2019 Jan; 10(1):120. PubMed ID: 30631056 [TBL] [Abstract][Full Text] [Related]
36. Recent insight into the correlation of SREBP-mediated lipid metabolism and innate immune response. Park HY; Kang HS; Im SS J Mol Endocrinol; 2018 Oct; 61(3):R123-R131. PubMed ID: 30307160 [TBL] [Abstract][Full Text] [Related]